Shaymaa Bahnassy
@sbahnassy17.bsky.social
Cancer Research Scientist 👩🏻🔬 🧫 🧬 @LombardiCancer I #Breastcancer I PhD @uhnsm.bsky.social I Exploring the World through Science and Travel 🔬 ✈️ 🌍
https://www.linkedin.com/in/shaymaabahnassy/
https://www.linkedin.com/in/shaymaabahnassy/
I enjoyed reading this well-thought-out review on clinical challenges and proposed solutions for patients with invasive #lobular #breastcancer Oncologyhttps://www.annalsofoncology.org/article/S0923-7534%2825%2900857-9/fulltext
Clinical challenges and proposed solutions for patients with invasive lobular breast cancer
Invasive lobular carcinoma (ILC) is the second most common type of breast cancer and
is increasingly recognized as a separate entity from invasive breast cancer of no-special
type. Here, we present th...
www.annalsofoncology.org
July 24, 2025 at 11:25 PM
I enjoyed reading this well-thought-out review on clinical challenges and proposed solutions for patients with invasive #lobular #breastcancer Oncologyhttps://www.annalsofoncology.org/article/S0923-7534%2825%2900857-9/fulltext
Reposted by Shaymaa Bahnassy
We did a thing w @jostrander.bsky.social!
Over the last few years, we took a new direction into #lobular breast cancer oncogenesis. We know loss of the gene CDH1 (E-cadherin) is central to ILC, and is among its earliest oncogenic events. But why? How does this push normal breast toward cancer? 1/n
Over the last few years, we took a new direction into #lobular breast cancer oncogenesis. We know loss of the gene CDH1 (E-cadherin) is central to ILC, and is among its earliest oncogenic events. But why? How does this push normal breast toward cancer? 1/n
CDH1 loss remodels gene expression and lineage identity in human mammary epithelial cells https://www.biorxiv.org/content/10.1101/2025.06.20.660633v1
June 25, 2025 at 5:26 PM
We did a thing w @jostrander.bsky.social!
Over the last few years, we took a new direction into #lobular breast cancer oncogenesis. We know loss of the gene CDH1 (E-cadherin) is central to ILC, and is among its earliest oncogenic events. But why? How does this push normal breast toward cancer? 1/n
Over the last few years, we took a new direction into #lobular breast cancer oncogenesis. We know loss of the gene CDH1 (E-cadherin) is central to ILC, and is among its earliest oncogenic events. But why? How does this push normal breast toward cancer? 1/n
Reposted by Shaymaa Bahnassy
New review from us on radiation in #lobular breast cancer!
www.nature.com/articles/s41...
Lots of anecdote that ILC is highly responsive to XRT (despite ~chemoresistance), but do we have the data?
led by Dr. Michael Boysen (now resident at Trinity Health Ann Arbor), w Dr. Corey Speers @ UAB. 🧵1/n
www.nature.com/articles/s41...
Lots of anecdote that ILC is highly responsive to XRT (despite ~chemoresistance), but do we have the data?
led by Dr. Michael Boysen (now resident at Trinity Health Ann Arbor), w Dr. Corey Speers @ UAB. 🧵1/n
Radiation therapy for lobular breast cancer: opportunities and challenges for leveraging radiosensitivity - npj Breast Cancer
npj Breast Cancer - Radiation therapy for lobular breast cancer: opportunities and challenges for leveraging radiosensitivity
www.nature.com
July 10, 2025 at 3:33 PM
New review from us on radiation in #lobular breast cancer!
www.nature.com/articles/s41...
Lots of anecdote that ILC is highly responsive to XRT (despite ~chemoresistance), but do we have the data?
led by Dr. Michael Boysen (now resident at Trinity Health Ann Arbor), w Dr. Corey Speers @ UAB. 🧵1/n
www.nature.com/articles/s41...
Lots of anecdote that ILC is highly responsive to XRT (despite ~chemoresistance), but do we have the data?
led by Dr. Michael Boysen (now resident at Trinity Health Ann Arbor), w Dr. Corey Speers @ UAB. 🧵1/n
Reposted by Shaymaa Bahnassy
EMT and cancer: what clinicians should know doi.org/10.1038/s415...
EMT and cancer: what clinicians should know - Nature Reviews Clinical Oncology
Despite several decades of research that has revealed roles in the development and progression of many solid tumours, clinical translation of research targeting epithelial–mesenchymal transition (EMT)...
doi.org
July 23, 2025 at 6:03 PM
EMT and cancer: what clinicians should know doi.org/10.1038/s415...
Reposted by Shaymaa Bahnassy
Check out the newest #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (May 5th-11th, 2025). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch
May 12, 2025 at 1:11 PM
Check out the newest #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (May 5th-11th, 2025). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch
Reposted by Shaymaa Bahnassy
Can dynamic precision medicine prevent late relapse? A new study published in JCO Precision Oncology delves into the Generalized Evolutionary Classifier and its potential benefits for patients. Read the full article co-authored by @sbahnassy17.bsky.social & @profriggins.bsky.social: brnw.ch/21wRt03
Generalized Evolutionary Classifier for Evolutionary Guided Precision Medicine | JCO Precision Oncology
PURPOSECurrent precision medicine (CPM) matches patients to therapies using traditional biomarkers,
but inevitably resistance develops. Dynamic precision medicine (DPM) is a new evolutionary
guided pr...
ascopubs.org
March 20, 2025 at 5:08 PM
Can dynamic precision medicine prevent late relapse? A new study published in JCO Precision Oncology delves into the Generalized Evolutionary Classifier and its potential benefits for patients. Read the full article co-authored by @sbahnassy17.bsky.social & @profriggins.bsky.social: brnw.ch/21wRt03
Reposted by Shaymaa Bahnassy
The BRIDGES study @JCO GO
❓ Management of IBC in low and middle income countries
✅ 112 responses from clinicians from 36 counties
🔑 1/3 of patients with non metastatic IBC are receiving TMT
🔑 provider education everywhere is key to improve patient outcomes
ascopubs.org/doi/pdf/10.1...
❓ Management of IBC in low and middle income countries
✅ 112 responses from clinicians from 36 counties
🔑 1/3 of patients with non metastatic IBC are receiving TMT
🔑 provider education everywhere is key to improve patient outcomes
ascopubs.org/doi/pdf/10.1...
December 20, 2024 at 9:12 PM
The BRIDGES study @JCO GO
❓ Management of IBC in low and middle income countries
✅ 112 responses from clinicians from 36 counties
🔑 1/3 of patients with non metastatic IBC are receiving TMT
🔑 provider education everywhere is key to improve patient outcomes
ascopubs.org/doi/pdf/10.1...
❓ Management of IBC in low and middle income countries
✅ 112 responses from clinicians from 36 counties
🔑 1/3 of patients with non metastatic IBC are receiving TMT
🔑 provider education everywhere is key to improve patient outcomes
ascopubs.org/doi/pdf/10.1...
Reposted by Shaymaa Bahnassy
Applications are *now open* for our Summer 2025 American Cancer Society Diversity in Cancer Research *paid* summer internship program at Georgetown Lombardi Comprehensive Cancer! $5K stipend, free campus housing, 10 weeks of hands-on cancer research for undergrads. No citizenship restrictions! 🧪🧬👩🔬
Diversity in Cancer Research Undergraduate Internship Program - Lombardi Comprehensive Cancer Center
Summer 2025 Program About the Program This program, sponsored by the American Cancer Society and Georgetown University, is open to rising college sophomores, juniors and seniors with an interest in ST...
lombardi.georgetown.edu
December 20, 2024 at 6:47 PM
Applications are *now open* for our Summer 2025 American Cancer Society Diversity in Cancer Research *paid* summer internship program at Georgetown Lombardi Comprehensive Cancer! $5K stipend, free campus housing, 10 weeks of hands-on cancer research for undergrads. No citizenship restrictions! 🧪🧬👩🔬
Reposted by Shaymaa Bahnassy
Proud of our Riggins Lab undergrad Dua Mobin for an awesome senior research presentation on imaging approaches to visualize #lobular breast cancer metabolism #bcsm @sbahnassy17.bsky.social @sumanranjit.bsky.social @mjsikora.bsky.social @zmadake2.bsky.social
December 13, 2024 at 4:24 PM
Proud of our Riggins Lab undergrad Dua Mobin for an awesome senior research presentation on imaging approaches to visualize #lobular breast cancer metabolism #bcsm @sbahnassy17.bsky.social @sumanranjit.bsky.social @mjsikora.bsky.social @zmadake2.bsky.social